Use of pde5 inhibitors in the treatment of scarring and...

Details Use of pde5 inhibitors in the treatment of scarring and... Use of pde5 inhibitors in the treatment of scarring and...

A - Human Necessities

61

K

A61K 31/522 (2006.01) A61P 11/00 (2006.01) A61P 17/02 (2006.01)

Patent

CA 2474852

This invention relates to the use of selective cyclic guanosine 3', 5'- monophosphate type five (cGMP PDE5} inhibitors (hereinafter PDE5 inhibitors), including in particular the compound sildenafil, for the treatment of or prevention of scarring or fibrosis in tissue.

L'invention concerne l'utilisation d'inhibiteurs sélectifs de la guanosine 3', 5'-monophosphate cyclique du type cinq (cGMP PDE5} (ci-après dénommés inhibiteurs de PDE5), comprenant notamment le composé sildénafil, pour le traitement ou la prévention de la formation de cicatrices et de la fibrose au niveau du tissu.

Affiliated with

Also associated with

Rating

Use of pde5 inhibitors in the treatment of scarring and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of pde5 inhibitors in the treatment of scarring and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pde5 inhibitors in the treatment of scarring and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2078252